|Articles|May 3, 2003
Levofloxacin gains market share in ophthalmic anti-infective category
Latest market analysis of prescription anti-infective pharmaceuticalsin the ophthalmic market shows that levofloxacin ophthalmic solution 0.5%(Quixin, Santen) has nearly doubled in market share over the previous year,reported Santen.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
2
Moorfields study reveals sharp rise in glaucoma burden across the UK
3
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
4
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
5










































